TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 65 filers reported holding TAYSHA GENE THERAPIES INC in Q3 2023. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 79 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 2,179,000 | $44,234,000 | 25.95% |
| Octagon Capital Advisors LP | 320,440 | $6,505,000 | 2.45% |
| Alphabet Inc. | 640,882 | $13,010,000 | 0.52% |
| Casdin Capital, LLC | 820,440 | $16,655,000 | 0.50% |
| Artal Group S.A. | 1,040,882 | $21,130,000 | 0.37% |
| VR Adviser, LLC | 120,649 | $2,449,000 | 0.27% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 500,000 | $10,150,000 | 0.22% |
| Perceptive Advisors | 470,440 | $9,548,000 | 0.12% |
| TimesSquare Capital Management, LLC | 397,200 | $8,063,000 | 0.07% |
| Sands Capital Management | 724,873 | $14,715,000 | 0.03% |